Every SEC Form 3/4/5 on record for this filer (CIK 1534261) — 10 issuers, 20 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
This filer is an entity, not a person. This reporting owner's name carries a corporate/fund legal form, so it is an ENTITY filing under Section 16 — typically a fund with a board-designation right or a 10% holder — not an individual. Its 'director' rows are the entity's designation right, not a person's board seat.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| WGS | GeneDx Holdings Corp. | Director | 2023-02-10 → 2026-06-08 | 11 | $4M |
| BLFS | BIOLIFE SOLUTIONS INC | 10% owner | 2018-08-15 → 2026-05-21 | 20 | $24M |
| LAB | STANDARD BIOTOOLS INC. | Director | 2022-04-06 → 2025-12-04 | 28 | $5M |
| TSVT | 2seventy bio, Inc. | Director | 2024-03-25 → 2025-05-15 | 5 | $204,000 |
| TNYA | Tenaya Therapeutics, Inc. | Director · lapsed | 2021-07-29 → 2022-11-25 | 3 | $6M |
| MXCT | MAXCYTE, INC. | 10% owner · lapsed | 2021-07-30 → 2022-10-05 | 4 | −$18M |
| ABSI | Absci Corp | Director · lapsed | 2021-07-21 → 2021-07-28 | 2 | $25M |
| GBIO | Generation Bio Co. | 10% owner · lapsed | 2020-06-11 → 2020-06-18 | 2 | — |
| FULC | Fulcrum Therapeutics, Inc. | 10% owner · lapsed | 2019-07-17 → 2019-07-22 | 2 | — |
| CNST | CONSTELLATION PHARMACEUTICALS INC | 10% owner · lapsed | 2018-07-18 → 2018-07-23 | 2 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| BLFS | 2025-08-15 | Sell | 500,000 | $24.40 | $12M | 6,707,165 |
| LAB | 2025-02-28 | Buy | 4,820,959 | $1.07 | $5M | 58,846,780 |
| WGS | 2024-06-04 | Buy | 30,000 | $22.52 | $675,600 | 3,093,509 |
| WGS | 2024-06-03 | Buy | 100,000 | $20.82 | $2M | 3,063,509 |
7 of 10 issuers are covered and open a security page; the rest are on file here only.
